Hemab Therapeutics Holdings, Inc. (COAG)
41.45
+1.03
(+2.55%)
USD |
NASDAQ |
Oct 30, 16:00
41.45
0.00 (0.00%)
After-Hours: 20:00
Hemab Therapeutics Holdings Price : 41.45 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 40.34 | 42.85 | 39.38 | 41.45 | 765616.0 |
| Oct 29, 2026 | 38.89 | 42.23 | 38.75 | 40.42 | 1.196M |
| Oct 28, 2026 | 38.23 | 38.78 | 37.26 | 38.50 | 414025.0 |
| Oct 27, 2026 | 36.35 | 38.58 | 35.40 | 38.40 | 380059.0 |
| Oct 26, 2026 | 34.73 | 36.38 | 34.39 | 36.02 | 269193.0 |
| Oct 23, 2026 | 34.58 | 36.70 | 33.89 | 34.40 | 271177.0 |
| Oct 22, 2026 | 35.20 | 35.90 | 34.44 | 34.82 | 368983.0 |
| Oct 21, 2026 | 34.17 | 36.32 | 34.13 | 35.34 | 388273.0 |
| Oct 20, 2026 | 32.16 | 34.53 | 31.32 | 34.17 | 397751.0 |
| Oct 19, 2026 | 30.12 | 32.37 | 29.88 | 32.09 | 254486.0 |
| Oct 16, 2026 | 32.56 | 32.56 | 29.87 | 30.07 | 351773.0 |
| Oct 15, 2026 | 30.20 | 33.50 | 30.20 | 32.52 | 478283.0 |
| Oct 14, 2026 | 29.75 | 30.42 | 29.01 | 29.94 | 224941.0 |
| Oct 13, 2026 | 30.59 | 31.05 | 29.11 | 29.80 | 441950.0 |
| Oct 12, 2026 | 31.68 | 32.14 | 30.20 | 30.39 | 235037.0 |
| Oct 09, 2026 | 30.65 | 33.93 | 29.98 | 31.62 | 619091.0 |
| Oct 08, 2026 | 28.60 | 31.31 | 27.39 | 30.89 | 616521.0 |
| Oct 07, 2026 | 28.25 | 28.98 | 27.38 | 28.70 | 377185.0 |
| Oct 06, 2026 | 30.81 | 30.89 | 28.01 | 28.37 | 436833.0 |
| Oct 05, 2026 | 31.11 | 31.11 | 29.76 | 30.59 | 294545.0 |
| Oct 02, 2026 | 31.49 | 31.49 | 30.06 | 31.11 | 354148.0 |
| Oct 01, 2026 | 30.82 | 31.35 | 29.63 | 31.06 | 437788.0 |
| Sep 30, 2026 | 32.92 | 33.27 | 30.80 | 30.84 | 865204.0 |
| Sep 29, 2026 | 32.99 | 33.95 | 31.80 | 32.60 | 452048.0 |
| Sep 28, 2026 | 34.39 | 34.41 | 32.60 | 33.12 | 348532.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 59.90 |
| Oncolytics Biotech, Inc. | 0.4254 |
| Sangamo Therapeutics, Inc. | 0.116 |
| Sarepta Therapeutics, Inc. | 18.62 |
| Anixa Biosciences, Inc. | 3.12 |
Price Related Metrics
| Price to Book Value | 4.262 |
| Earnings Yield | -3.84% |
| Market Cap | 1.936B |